These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28212684)

  • 1. The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry.
    Villeneuve L; Passot G; Glehen O; Isaac S; Bibeau F; Rousset P; Gilly FN;
    Orphanet J Rare Dis; 2017 Feb; 12(1):37. PubMed ID: 28212684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists].
    Villeneuve L; Isaac S; Glehen O; Capovilla M; Chevallier A; Croce S; Dartigues P; Fontaine J; Kaci R; Lang-Averous G; Laverriere MH; Leroux-Broussier A; Mery E; Poizat F; Valmary-Degano S; Verriele-Beurrier V; Gilly FN; Bibeau F
    Ann Pathol; 2014 Feb; 34(1):4-8. PubMed ID: 24630631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal cytokine level in patients with peritoneal surface malignancies. A study of the RENAPE (French Network for Rare Peritoneal Malignancies).
    Vlaeminck-Guillem V; Bienvenu J; Isaac S; Grangier B; Golfier F; Passot G; Bakrin N; Rodriguez-Lafrasse C; Gilly FN; Glehen O
    Ann Surg Oncol; 2013 Aug; 20(8):2655-62. PubMed ID: 23519518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [RENAPE network: Towards more equitable access to care and expertise for patients with rare peritoneal cancers].
    Villeneuve L; Odin C; Bonnefoy I; Pichon P; Valmary-Degano S; Bibeau F; ;
    Ann Pathol; 2024 Jul; 44(4):291-295. PubMed ID: 38839525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant primary peritoneal tumors].
    Cotte E; Passot G; Isaac S; Gilly FN; Glehen O
    Presse Med; 2009 Dec; 38(12):1814-22. PubMed ID: 19356892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
    Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
    Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB).
    Rubinstein YR; Groft SC; Bartek R; Brown K; Christensen RA; Collier E; Farber A; Farmer J; Ferguson JH; Forrest CB; Lockhart NC; McCurdy KR; Moore H; Pollen GB; Richesson R; Miller VR; Hull S; Vaught J
    Contemp Clin Trials; 2010 Sep; 31(5):394-404. PubMed ID: 20609392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001-2010.
    Brecht IB; Bremensdorfer C; Schneider DT; Frühwald MC; Offenmüller S; Mertens R; Vorwerk P; Koscielniak E; Bielack SS; Benesch M; Hero B; Graf N; von Schweinitz D; Kaatsch P
    Pediatr Blood Cancer; 2014 Jul; 61(7):1202-9. PubMed ID: 24585499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a pilot rare disease registry: a focus group study of initial steps towards the establishment of a rare disease ecosystem in Slovenia.
    Stanimirovic D; Murko E; Battelino T; Groselj U
    Orphanet J Rare Dis; 2019 Jul; 14(1):172. PubMed ID: 31288838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey.
    Ferron G; Simon L; Guyon F; Glehen O; Goere D; Elias D; Pocard M; Gladieff L; Bereder JM; Brigand C; Classe JM; Guilloit JM; Quenet F; Abboud K; Arvieux C; Bibeau F; De Chaisemartin C; Delroeux D; Durand-Fontanier S; Goasguen N; Gouthi L; Heyd B; Kianmanesh R; Leblanc E; Loi V; Lorimier G; Marchal F; Mariani P; Mariette C; Meeus P; Msika S; Ortega-Deballon P; Paineau J; Pezet D; Piessen G; Pirro N; Pomel C; Porcheron J; Pourcher G; Rat P; Regimbeau JM; Sabbagh C; Thibaudeau E; Torrent JJ; Tougeron D; Tuech JJ; Zinzindohoue F; Lundberg P; Herin F; Villeneuve L;
    Eur J Surg Oncol; 2015 Oct; 41(10):1361-7. PubMed ID: 26263848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10 years of CEMARA database in the AnDDI-Rares network: a unique resource facilitating research and epidemiology in developmental disorders in France.
    Messiaen C; Racine C; Khatim A; Soussand L; Odent S; Lacombe D; Manouvrier S; Edery P; Sigaudy S; Geneviève D; Thauvin-Robinet C; Pasquier L; Petit F; Rossi M; Willems M; Attié-Bitach T; Roux-Levy PH; Demougeot L; Slama LB; Landais P; ; Jannot AS; Binquet C; Sandrin A; Verloes A; Faivre L
    Orphanet J Rare Dis; 2021 Aug; 16(1):345. PubMed ID: 34348744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evidence-based medicine model for rare and often neglected neoplastic conditions.
    Fisher CG; Goldschlager T; Boriani S; Varga PP; Rhines LD; Fehlings MG; Luzzati A; Dekutoski MB; Reynolds JJ; Chou D; Berven SH; Williams RP; Quraishi NA; Bettegowda C; Gokaslan ZL
    J Neurosurg Spine; 2014 Nov; 21(5):704-10. PubMed ID: 25192373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of patients' cohorts in the French National rare disease registry.
    Pichon T; Messiaen C; Soussand L; Angin C; Sandrin A; Elarouci N; Jannot AS;
    Orphanet J Rare Dis; 2023 Jul; 18(1):176. PubMed ID: 37400917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model.
    Bellgard MI; Napier KR; Bittles AH; Szer J; Fletcher S; Zeps N; Hunter AA; Goldblatt J
    Blood Cells Mol Dis; 2018 Feb; 68():232-238. PubMed ID: 28190666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland.
    Solon JG; O'Neill M; Chang KH; Deady S; Cahill R; Moran B; Shields C; Mulsow J
    Eur J Surg Oncol; 2017 Oct; 43(10):1924-1931. PubMed ID: 28583791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New clinical research strategies for rare gynecologic malignancies.
    Ray-Coquard I; Pujade-Lauraine E; Ledermann JA
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):53-7. PubMed ID: 25490380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Italian National Rare Diseases Registry.
    Taruscio D; Kodra Y; Ferrari G; Vittozzi L;
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s606-13. PubMed ID: 24922301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the feasibility of a web-based registry for multiple orphan lung diseases: the Australasian Registry Network for Orphan Lung Disease (ARNOLD) experience.
    Casamento K; Laverty A; Wilsher M; Twiss J; Gabbay E; Glaspole I; Jaffe A;
    Orphanet J Rare Dis; 2016 Apr; 11():42. PubMed ID: 27090393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.